PEPTIDE CORPUS

718 gaps · 163 records · 20 fields

What we do not know, enumerated

A blank field is a bug. A named absence is a finding. These 718 say which field is empty, on which record, and why — so the shape of what we hold can be checked rather than assumed.

Last updated

718declared gaps
163records affected
20fields
587nothing we hold supplies it
41no source on file holds this
41the reference database returned nothing
28not applicable to the compound
3no pharmacokinetic study in any species on file
1no study reports one, and the circulated 20-30 hours traces to supplier copy
1measured in two rat studies whose numbers sit behind a paywall
1the only figure published is quoted from the sponsor's investigator's brochure
1phase 1 studies are published, but both full texts are paywalled and neither abstract states one
1stated only in a sponsor press release, with no assay or sample size
1no human study of hgh 176-191 or hgh 177-191 is on file; the human trial history belongs to aod9604, a different molecule
1no published human dose; the rodent doses are recorded in csvdosing and do not transfer
1no primary source states a use concentration; supplier figures are not on file as primary
1no stability or concentration record from a primary source; vial sizes in trade are vendor claims
1a topical cosmetic ingredient supplied in solution, so the vial-and-diluent model does not apply
1no controlled safety data in humans; the entry records one rodent finding and nothing else
1no dedicated safety assessment of this peptide found; the tolerability figures on file belong to combination products
1no approved product, and no fda evaluation of this fragment exists; the december 2024 compounding review on file examines aod-9604, a different molecule
1the trade name says 176-191 and the literature says 177-191; the two differ by an n-terminal phenylalanine, and which one a given vial contains is not established by any source on file
1no published study tested acetyl octapeptide-3 as the only active; both human studies on file used multi-ingredient products
1no in vitro or cell experiment on this sequence found; the snare-interference account rests on peptides copied from other snare motifs
1no permeation or penetration measurement for this peptide on file
1not named on the 2026 prohibited list; whether the s0 catch-all reaches it was not resolved from a wada source

A gap is a claim, not a blank

Every row here asserts something: that we looked for a specific value on a specific record and did not find one that met the bar. That is different from a field nobody filled in. A blank invites you to supply the answer from the surrounding text; a named absence tells you not to. The grading rubric covers what qualifies as a source.

By field

Nothing we hold supplies it

No source on file holds this

The reference database returned nothing

Not applicable to the compound

no pharmacokinetic study in any species on file

no study reports one, and the circulated 20-30 hours traces to supplier copy

measured in two rat studies whose numbers sit behind a paywall

the only figure published is quoted from the sponsor's investigator's brochure

phase 1 studies are published, but both full texts are paywalled and neither abstract states one

stated only in a sponsor press release, with no assay or sample size

no published human dose; the rodent doses are recorded in csvDosing and do not transfer

no primary source states a use concentration; supplier figures are not on file as primary

no stability or concentration record from a primary source; vial sizes in trade are vendor claims

a topical cosmetic ingredient supplied in solution, so the vial-and-diluent model does not apply

no controlled safety data in humans; the entry records one rodent finding and nothing else

no dedicated safety assessment of this peptide found; the tolerability figures on file belong to combination products

no approved product, and no FDA evaluation of this fragment exists; the December 2024 compounding review on file examines AOD-9604, a different molecule

no human study of hGH 176-191 or hGH 177-191 is on file; the human trial history belongs to AOD9604, a different molecule

no published study tested acetyl octapeptide-3 as the only active; both human studies on file used multi-ingredient products

no in vitro or cell experiment on this sequence found; the SNARE-interference account rests on peptides copied from other SNARE motifs

the trade name says 176-191 and the literature says 177-191; the two differ by an N-terminal phenylalanine, and which one a given vial contains is not established by any source on file

no permeation or penetration measurement for this peptide on file

not named on the 2026 Prohibited List; whether the S0 catch-all reaches it was not resolved from a WADA source

By record

163 of the 188 records are missing at least one of the eight fields tracked here. The other 25 hold all eight.

This count is taken from the records themselves rather than from what a source admitted to. It used to be the other way round, and it read as a much better number: 166 records had no source-declared gaps and showed “not on file: 0” — including one holding none of the eight fields at all.

RecordGapsFields holding nothing
Adamax 10
Agouti-Related Protein (AgRP) 10
Brinp-2 Related Peptide (BRP) 10
CART (Cocaine- and Amphetamine-Regulated Transcript) 10
Cecropins 10
Chemerin 10
Dermcidin 10
hCG 10
Hyaluronic Acid Binding Peptide 10
Nesfatin-1 10
Obestatin 10
Omentin 10
P21 10
PEA 10
Psoriasin (S100A7) 10
RNase 7 10
Temporins 10
Thymalin 10
Vaspin 10
5-Amino-1MQ 9
Bactericidal/Permeability-Increasing Protein (BPI) 9
Bacteriocins 9
Carnosic Acid 9
Cartilage Peptides 9
Cerebrolysin 9
Cholecystokinin (CCK) 9
Collagen Peptides 9
Cortexin 9
CRH (Corticotropin-Releasing Hormone) 9
Defensins 9
Dynorphin A 9
Elabela 9
Elastin Peptides 9
GIP (Gastric Inhibitory Peptide) 9
hGH 9
Histatins 9
IGF-1 LR3 9
Irisin 9
Magainins 9
Proline-rich Antimicrobial Peptides (PrAMPs) 9
Silk Peptides 9
Simonson Alpha 1 9
Soy Peptides 9
Urocortin 9
VK2735 9
Wheat Peptides 9
β-Endorphin 9
Adiponectin 8
CJC-1295 DAC 8
DHEA 8
Estradiol 8
HGH Frag 176-191 8
Progesterone 8
Relaxin 8
Retatrutide 8
Snap-8 8
Testosterone 8
Vasopressin 8
IGF-1 7
Brain Natriuretic Peptide (BNP) 3
Galantide 3
L-Carnitine 3
NAD+ 3
Oligopeptide-34 3
Orexin-B 3
PGLa 3
PYY3-36 3
Sauvagine 3
Survodutide 3
Acetyl Tetrapeptide-11 2
Acetyl Tetrapeptide-5 2
Acetyl Tetrapeptide-9 2
Angiotensin (1-7) 2
Angiotensin I 2
Angiotensin II 2
Anserine 2
Apelin 2
Argireline (Acetyl Hexapeptide-3) 2
Balenine 2
Boceprevir 2
Bombesin 2
Bradykinin 2
Carnosine 2
Cartalax 2
Decapeptide-12 2
Dipeptide Diaminobutyroyl Benzylamide Diacetate 2
Endothelin-1 2
Galanin 2
GHK (Glycyl-L-Histidyl-L-Lysine) 2
Glutathione 2
GnRH (Gonadotropin-Releasing Hormone) 2
Hexapeptide-11 2
Hexapeptide-9 2
Lactoferricin 2
Leu-Enkephalin 2
LL-37 (Cathelicidin) 2
Melanotan II 2
Melittin 2
Met-Enkephalin 2
MK-677 2
Motilin 2
Myristoyl Pentapeptide-17 2
NAD+ Boosting / Precursor Peptides 2
Neuropeptide Y 2
Neurotensin 2
Nisin 2
Nociceptin 2
Nonapeptide-1 2
Noopept 2
Orexin-A 2
PACAP (Pituitary Adenylate Cyclase-Activating Peptide) 2
Palmitoyl Hexapeptide-12 2
Palmitoyl Pentapeptide-4 (Matrixyl) 2
Palmitoyl Tetrapeptide-7 2
Palmitoyl Tripeptide-1 2
Palmitoyl Tripeptide-38 2
Pentapeptide-18 2
Sofosbuvir 2
Substance P 2
Telaprevir 2
Tetrapeptide-21 2
Tetrapeptide-30 2
Thymosin Beta-4 2
Tripeptide-10 Citrulline 2
Tripeptide-29 2
Urotensin II 2
Adrenomedullin 1
AOD-9604 1
ARA-290 1
Atrial Natriuretic Peptide (ANP) 1
C-Type Natriuretic Peptide (CNP) 1
CJC-1295 no-DAC 1
Dihexa 1
Epitalon 1
Exenatide 1
Exendin-4 1
FOXO4-DRI 1
Gastrin 1
GHK-Cu 1
Ghrelin 1
GHRH (Growth Hormone-Releasing Hormone) 1
GHRP-1 1
GHRP-6 1
GLP-2 (Teduglutide) 1
Gonadorelin 1
Guanylin 1
Humanin 1
Kisspeptin-10 1
KPV 1
MOTS-c 1
N-Acetylcysteine (NAC) 1
Nesiritide 1
Oxytocin 1
Pinealon 1
Secretin 1
Selank 1
Semax 1
SS-31 1
Thymopentin 1
Thymulin 1
Tirzepatide 1
Uroguanylin 1
VIP 1

What this ledger does not cover

These 718 are the gaps on records we publish. An earlier version of this count said 1,515, and 1,227 of those belonged to 158 rows that were never compounds — scraped seller page titles ingested as records, including HTTP error pages, order-tracking screens and blog posts. They are excluded at the export step rather than filtered here, because data that cannot be published should not reach the page layer at all.

It covers eight fields, and only those: molecular weight and formula, CAS number, PubChem CID, amino-acid sequence, SMILES, InChI and InChI key. A record holding all eight is complete by this measure and not in any wider sense — no dosing, no pharmacokinetics, and nothing about evidence, which the rubric handles separately.

Until recently it also covered only what a source had declared missing, which made it a report on our sources' paperwork rather than on our data. 166 records had no declaration and showed “not on file: 0”, one of them while holding none of the eight fields. The rows are now counted from the records themselves, which is why this number went up rather than down.